doi: 10.1089/apc.2009.0263.
Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV
- PMID: 20095911
- DOI: 10.1089/apc.2009.0263
Item in Clipboard
Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV
AIDS Patient Care STDS.
2010 Jan.
No abstract available
Similar articles
-
Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.Infect Control Hosp Epidemiol. 2007 Jun;28(6):695-701. doi: 10.1086/518349. Epub 2007 May 8. Infect Control Hosp Epidemiol. 2007. PMID: 17520543
-
Pre-exposure prophylaxis for HIV infection: what if it works?Lancet. 2007 Jul 7;370(9581):89-93. doi: 10.1016/S0140-6736(07)61053-8. Lancet. 2007. PMID: 17617276 Review. No abstract available.
-
Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.AIDS Patient Care STDS. 2008 Apr;22(4):279-90. doi: 10.1089/apc.2007.0141. AIDS Patient Care STDS. 2008. PMID: 18290748 Clinical Trial.
-
[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].Med Mal Infect. 2013 Mar;43(3):134-5. doi: 10.1016/j.medmal.2013.01.008. Epub 2013 Feb 20. Med Mal Infect. 2013. PMID: 23434355 French. No abstract available.
-
[Role of tenofovir in HIV and hepatitis C virus coinfection].Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:31-7. doi: 10.1157/13126270. Enferm Infecc Microbiol Clin. 2008. PMID: 19195436 Review. Spanish.
Cited by
-
Longitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013.J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):97-101. doi: 10.1097/QAI.0000000000000403. J Acquir Immune Defic Syndr. 2015. PMID: 25321180 Free PMC article.
-
Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.AIDS. 2014 Jul 17;28(11):1545-54. doi: 10.1097/QAD.0000000000000301. AIDS. 2014. PMID: 24785956 Free PMC article. Review.
-
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).Open Forum Infect Dis. 2023 Jul 19;10(8):ofad374. doi: 10.1093/ofid/ofad374. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37539061 Free PMC article.
-
Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):535-539. doi: 10.1097/QAI.0000000000001440. J Acquir Immune Defic Syndr. 2017. PMID: 28696345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
